Results 131 to 140 of about 50,069 (258)

Commentary on Mereish et al.: Supporting sexually diverse youth requires a full spectrum understanding of substance use

Addiction, EarlyView.
Kira London‐Nadeau, Charlie Rioux
wiley   +1 more source

Is there a role for cannabidiol in obesity, metabolic syndrome and binge eating?

British Journal of Pharmacology, EarlyView.
Cannabidiol (CBD) is one of the most abundant phytocannabinoids isolated from the Cannabis sativa plant. CBD is a lipophilic, non‐intoxicating substance that differently from Δ9‐tetrahydrocannabinol (Δ9‐THC) does not present the typical profile of a drug of abuse.
Luca Botticelli, Emanuela Micioni Di Bonaventura, Giacomo Einaudi, Gustavo Provensi, Alessia Costa, Claudio D'Addario, Carlo Cifani, Maria Vittoria Micioni Di Bonaventura   +7 more
wiley   +1 more source

Medical cannabis authorization and opioid milligram equivalents over time in patients with chronic pain: a retrospective analysis. [PDF]

Pain Med
Sexton M, Glodosky NC, Cleveland M, Cuttler C, Lee E, Polston GR, Furnish T, Lerman I, Schuster NM, Wallace MS.   +9 more
europepmc   +1 more source

Sex‐specific impact of repeated adolescent vapour exposure to JWH‐018 on dopamine response, behaviour and pharmacokinetics across adolescence and adulthood

British Journal of Pharmacology, EarlyView.
Abstract Background and Purpose Alarming trends show that vaping e‐cigarettes containing synthetic cannabinoid receptor agonists, such as JWH‐018, is increasing among youth. However, the effects of these trends are unclear in both sexes. We therefore characterized the neuropharmacological effects of adolescent JWH‐018 inhalation in male and female rats.
Nicholas Pintori, Cristina Manis, Enrica Spano, Nicola Simola, Alessandro Ieraci, Pierluigi Caboni, Gaetano Di Chiara, Maria Antonietta De Luca   +7 more
wiley   +1 more source

Post-legalization rise in German medical cannabis interest: evidence from Google trends as surrogate marker. [PDF]

J Cannabis Res
Kirchberger MC.
europepmc   +1 more source

Authorizing medical cannabis for children [PDF]

Paediatrics & Child Health, 2020
openaire   +4 more sources

Novel approaches for drug development against chronic primary pain: A systematic review

British Journal of Pharmacology, EarlyView.
Abstract Chronic primary pain (CPP) persisting for more than 3 months, associated with significant emotional distress without any known underlying cause, is an unmet medical need. Traditional or adjuvant analgesics do not provide satisfactory pain relief for a great proportion of these patients.
Valéria Tékus, Éva Borbély, Andreas Goebel, Ralf Baron, Zsófia Hajna, Zsuzsanna Helyes   +5 more
wiley   +1 more source

From farm to bedside: Potential of medical cannabis in global health. [PDF]

Complement Ther Med
Tendwa MB, Appidi T, Chitsunge B, Moreau M, Okole B, Kalombo L, Mallum A, Ngoma T, Weadock DP, Tanifum E, Erridge S, Sodergren M, Sims R, Johnson C, Toyang N, Lowe H, Ziberi B, Richner L, Carrillo S, Avery S, Pretorius J, Chikwamba R, Biteghe FAN, Grinspoon P, Strichtartz G, Yasmin-Karim S, Ngwa W.   +26 more
europepmc   +1 more source

Cannabigerol reverses mechanical allodynia through α2A‐adrenergic modulation of thalamocortical signaling in chemotherapy‐induced neuropathy

British Journal of Pharmacology, EarlyView.
Abstract Background and Purpose Chemotherapy‐induced peripheral neuropathy (CIPN) is a prevalent and treatment‐resistant side effect of platinum‐based chemotherapy, characterised by mechanical allodynia. Cannabigerol (CBG), a non‐psychoactive cannabinoid, has shown antinociceptive potential, but its site and mechanism of action remain unclear.
Quinn W. Wade, Nathan Morris, Diana E. Sepulveda, Alonso Cortez‐Resendiz, Christopher Brandl, Jennifer E. Lausch, Mariya Starostina, Nicholas M. Graziane   +7 more
wiley   +1 more source

Misinformation About Medical Cannabis in YouTube Videos: Systematic Review. [PDF]

JMIR Form Res
Khare S, Erridge S, Chidambaram S, Sodergren MH.   +3 more
europepmc   +1 more source